Skip to main content
Top
Published in: International Urology and Nephrology 8/2016

01-08-2016 | Urology - Original Paper

Analysis of vitamin D deficiency in calcium stone-forming patients

Authors: María Sierra Girón-Prieto, María del Carmen Cano-García, Miguel Ángel Arrabal-Polo, Antonio Poyatos-Andujar, Miguel Quesada-Charneco, Tomás de Haro-Muñoz, Salvador Arias-Santiago, Miguel Arrabal-Martín

Published in: International Urology and Nephrology | Issue 8/2016

Login to get access

Abstract

Purpose

The aim of this study is to analyse the percentage of hypovitaminosis D, as well as its relationship with the various parameters of calcium-phosphate metabolism.

Methods

A case control study was conducted on 366 patients, divided into two groups: Group 1: 127 non-stone-forming patients, and Group 2: 239 calcium stone forming. A study was performed on calcium-phosphate metabolism and urinary lithogenic factors. The percentage of vitamin D deficiency (25-OH-vitamin D levels <20 ng/ml) between the groups was analysed and compared. The SPSS 20.0 statistics program was used for the analysis, with a p ≤ .05 being considered significant.

Results

The mean age of Group 1 was 52.1 years compared to 49.6 years in Group 2, with no significant differences (p = .07). Vitamin D levels were lower in Group 2 compared to Group 1 (25.7 vs. 28.4 ng/ml, p = .02). A vitamin D deficiency was observed in 28 % of the Group 2 stone-forming patients versus 15.7 % in Group 1 (p = .009), with an odds ratio (OR) of 2.09 (95 % CI; 1.19–3.63). In the stone-forming patients with a vitamin D deficiency, the only difference observed was the higher levels of iPTH compared to those stone-formers with a normal vitamin D (56.9 vs. 45.5 pg/ml, respectively; p = .0001).

Conclusion

Calcium stone-forming patients have lower mean levels of vitamin D and a higher percentage of hypovitaminosis D than in non-stone-forming patients. This was only related to increased iPTH levels, with urine calcium and other lithogenic parameters having no obvious effect.
Literature
1.
go back to reference Tang J, Chonchol MB (2013) Vitamin D and kidney stone disease. Curr Opin Nephrol Hypertens 22:383–389CrossRefPubMed Tang J, Chonchol MB (2013) Vitamin D and kidney stone disease. Curr Opin Nephrol Hypertens 22:383–389CrossRefPubMed
3.
go back to reference Pipili C, Sekecioglu N, Oreopoulos DG (2012) Normocalcemic hyperparathyroidism in patients with recurrent kidney stones: a disease entity or vitamin D deficiency? Clin Nephrol 77:352–357CrossRefPubMed Pipili C, Sekecioglu N, Oreopoulos DG (2012) Normocalcemic hyperparathyroidism in patients with recurrent kidney stones: a disease entity or vitamin D deficiency? Clin Nephrol 77:352–357CrossRefPubMed
4.
go back to reference Hansen KE, Jones AN, Lindstrom MJ, Davis LA, Engelke JA, Shafer MM (2008) Vitamin D insufficiency: disease or no disease? J Bone Miner Res 23:1052–1060CrossRefPubMedPubMedCentral Hansen KE, Jones AN, Lindstrom MJ, Davis LA, Engelke JA, Shafer MM (2008) Vitamin D insufficiency: disease or no disease? J Bone Miner Res 23:1052–1060CrossRefPubMedPubMedCentral
5.
go back to reference Nguyen S, Baggerly L, French C, Heaney RP, Gorham ED, Garland CF (2014) 25-Hydroxyvitamin D in the range of 20 to 100 ng/mL and incidence of kidney stones. Am J Public Health 104:1783–1787CrossRefPubMed Nguyen S, Baggerly L, French C, Heaney RP, Gorham ED, Garland CF (2014) 25-Hydroxyvitamin D in the range of 20 to 100 ng/mL and incidence of kidney stones. Am J Public Health 104:1783–1787CrossRefPubMed
6.
go back to reference Ticinesi A, Nouvenne A, Ferraro PM, Folesani G, Lauretani F, Allegri F, Guerra A, Cerundolo N, Aloe R, Lippi G, Maggio M, Gambaro G, Borghi L, Meschi T (2015) Idiopathic calcium nephrolithiasis and hypovitaminosis D: a case-control study. Urology. doi:10.1016/j.urology.2015.10.009 PubMed Ticinesi A, Nouvenne A, Ferraro PM, Folesani G, Lauretani F, Allegri F, Guerra A, Cerundolo N, Aloe R, Lippi G, Maggio M, Gambaro G, Borghi L, Meschi T (2015) Idiopathic calcium nephrolithiasis and hypovitaminosis D: a case-control study. Urology. doi:10.​1016/​j.​urology.​2015.​10.​009 PubMed
7.
go back to reference Penniston KL, Jones AN, Nakada SY, Hansen KE (2009) Vitamin D repletion does not alter urinary calcium excretion in healthy postmenopausal women. BJU Int 104:1512–1516CrossRefPubMedPubMedCentral Penniston KL, Jones AN, Nakada SY, Hansen KE (2009) Vitamin D repletion does not alter urinary calcium excretion in healthy postmenopausal women. BJU Int 104:1512–1516CrossRefPubMedPubMedCentral
8.
go back to reference Haghighi A, Samimagham H, Gohardehi G (2013) Calcium and vitamin D supplementation and risk of kidney stone formation in postmenopausal women. Iran J Kidney Dis 7:210–213PubMed Haghighi A, Samimagham H, Gohardehi G (2013) Calcium and vitamin D supplementation and risk of kidney stone formation in postmenopausal women. Iran J Kidney Dis 7:210–213PubMed
9.
go back to reference Blann A (2015) An update on vitamin D deficiency and at risk groups. J Fam Health 25:16–19PubMed Blann A (2015) An update on vitamin D deficiency and at risk groups. J Fam Health 25:16–19PubMed
10.
go back to reference Kalra S, Aggarwal S (2015) Vitamin D deficiency: diagnosis and patient centred management. J Pak Med Assoc 65:569–573PubMed Kalra S, Aggarwal S (2015) Vitamin D deficiency: diagnosis and patient centred management. J Pak Med Assoc 65:569–573PubMed
11.
go back to reference Wierzbicka J, Piotrowska A, Żmijewski MA (2014) The renaissance of vitamin D. Acta Biochim Pol 61:679–686PubMed Wierzbicka J, Piotrowska A, Żmijewski MA (2014) The renaissance of vitamin D. Acta Biochim Pol 61:679–686PubMed
12.
go back to reference Fallahzadeh MH, Zare J, Al-Hashemi GH, Derakhshan A, Basiratnia M, Arasteh MM, Fallahzadeh MA, Fallahzadeh MK (2012) Elevated serum levels of Vitamin D in infants with urolithiasis. Iran J Kidney Dis 6:186–191PubMed Fallahzadeh MH, Zare J, Al-Hashemi GH, Derakhshan A, Basiratnia M, Arasteh MM, Fallahzadeh MA, Fallahzadeh MK (2012) Elevated serum levels of Vitamin D in infants with urolithiasis. Iran J Kidney Dis 6:186–191PubMed
13.
go back to reference Shakhssalim N, Gilani KR, Parvin M, Torbati PM, Kashi AH, Azadvari M, Golestan B, Basiri A (2011) An assessment of parathyroid hormone, calcitonin, 1,25 (OH)2 vitamin D3, estradiol and testosterone in men with active calcium stone disease and evaluation of its biochemical risk factors. Urol Res 39:1–7CrossRefPubMed Shakhssalim N, Gilani KR, Parvin M, Torbati PM, Kashi AH, Azadvari M, Golestan B, Basiri A (2011) An assessment of parathyroid hormone, calcitonin, 1,25 (OH)2 vitamin D3, estradiol and testosterone in men with active calcium stone disease and evaluation of its biochemical risk factors. Urol Res 39:1–7CrossRefPubMed
14.
go back to reference Adams JS (1996) Regulation and actions of vitamin D. In: Coe F, Favus M, Pak C, Parks J, Preminger G (eds) Kidney stones. Medical and surgical management. Lippincott-Raven, Philadelphia Adams JS (1996) Regulation and actions of vitamin D. In: Coe F, Favus M, Pak C, Parks J, Preminger G (eds) Kidney stones. Medical and surgical management. Lippincott-Raven, Philadelphia
15.
go back to reference Sakhaee K, Maalouf N, Kumar R et al (2011) Nephrolithiasis-associated bone disease: pathogenesis and treatment options. Kidney Int 79:393–403CrossRefPubMed Sakhaee K, Maalouf N, Kumar R et al (2011) Nephrolithiasis-associated bone disease: pathogenesis and treatment options. Kidney Int 79:393–403CrossRefPubMed
16.
go back to reference Tang J, McFann K, Chonchol M (2012) Association between serum 25-hydroxyvitamin D and nephrolithiasis: the National Health and Nutrition Examination Survey III, 1988–94. Nephrol Dial Transpl 27:4385–4389CrossRef Tang J, McFann K, Chonchol M (2012) Association between serum 25-hydroxyvitamin D and nephrolithiasis: the National Health and Nutrition Examination Survey III, 1988–94. Nephrol Dial Transpl 27:4385–4389CrossRef
17.
go back to reference Pipili C, Oreopoulos DG (2012) Vitamin D status in patients with recurrent kidney stones. Nephron Clin Pract 122:134–138CrossRefPubMed Pipili C, Oreopoulos DG (2012) Vitamin D status in patients with recurrent kidney stones. Nephron Clin Pract 122:134–138CrossRefPubMed
18.
go back to reference Eisner BH, Thavaseelan S, Sheth S, Haleblian G, Pareek G (2012) Relationship between serum vitamin D and 24-hour urine calcium in patients with nephrolithiasis. Urology 80:1007–1010CrossRefPubMed Eisner BH, Thavaseelan S, Sheth S, Haleblian G, Pareek G (2012) Relationship between serum vitamin D and 24-hour urine calcium in patients with nephrolithiasis. Urology 80:1007–1010CrossRefPubMed
19.
go back to reference Elkoushy MA, Sabbagh R, Unikowsky B, Andonian S (2012) Prevalence and metabolic abnormalities of vitamin D-inadequate patients presenting with urolithiasis to a tertiary stone clinic. Urology 79:781–785CrossRefPubMed Elkoushy MA, Sabbagh R, Unikowsky B, Andonian S (2012) Prevalence and metabolic abnormalities of vitamin D-inadequate patients presenting with urolithiasis to a tertiary stone clinic. Urology 79:781–785CrossRefPubMed
20.
go back to reference Ketha H, Singh RJ, Grebe SK, Bergstralh EJ, Rule AD, Lieske JC, Kumar R (2015) Altered calcium and vitamin D homeostasis in first-time calcium kidney stone-formers. PLoS One 10:e0137350CrossRefPubMedPubMedCentral Ketha H, Singh RJ, Grebe SK, Bergstralh EJ, Rule AD, Lieske JC, Kumar R (2015) Altered calcium and vitamin D homeostasis in first-time calcium kidney stone-formers. PLoS One 10:e0137350CrossRefPubMedPubMedCentral
21.
go back to reference Leaf DE, Korets R, Taylor EN, Tang J, Asplin JR, Goldfarb DS, Gupta M, Curhan GC (2012) Effect of vitamin D repletion on urinary calcium excretion among kidney stone formers. Clin J Am Soc Nephrol 7:829–834CrossRefPubMed Leaf DE, Korets R, Taylor EN, Tang J, Asplin JR, Goldfarb DS, Gupta M, Curhan GC (2012) Effect of vitamin D repletion on urinary calcium excretion among kidney stone formers. Clin J Am Soc Nephrol 7:829–834CrossRefPubMed
22.
go back to reference Elkoushy MA, Jundi M, Lee TT, Andonian S (2014) Bone mineral density status in urolithiasis patients with vitamin D inadequacy followed at a tertiary stone centre. Can Urol Assoc J 8:323–328CrossRefPubMedPubMedCentral Elkoushy MA, Jundi M, Lee TT, Andonian S (2014) Bone mineral density status in urolithiasis patients with vitamin D inadequacy followed at a tertiary stone centre. Can Urol Assoc J 8:323–328CrossRefPubMedPubMedCentral
Metadata
Title
Analysis of vitamin D deficiency in calcium stone-forming patients
Authors
María Sierra Girón-Prieto
María del Carmen Cano-García
Miguel Ángel Arrabal-Polo
Antonio Poyatos-Andujar
Miguel Quesada-Charneco
Tomás de Haro-Muñoz
Salvador Arias-Santiago
Miguel Arrabal-Martín
Publication date
01-08-2016
Publisher
Springer Netherlands
Published in
International Urology and Nephrology / Issue 8/2016
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-016-1290-3

Other articles of this Issue 8/2016

International Urology and Nephrology 8/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine